GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
about
Ligand-modulation of the stability of the glucose transporter GLUT 1MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cellsExpression patterns of glucose transporter-1 gene and thyroid specific genes in human papillary thyroid carcinoma.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases.Development of a novel class of glucose transporter inhibitors.Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.Nuclear receptors and the Warburg effect in cancer.False positive localisation of C-11 methionine in a colloid nodule.PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.GLUT1 as a therapeutic target in hepatocellular carcinoma.Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?The human cell surfaceome of breast tumors.Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?[Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.Cytological evaluation by fine needle aspiration biopsy of incidental focal increased fluorodeoxyglucose uptake in thyroid on positron emission tomography scan.Metabolic Reprogramming in Thyroid Carcinoma.Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
P2860
Q28367387-A0AF1E73-6863-439A-8D02-3A8609563AD7Q28573488-8D22DEEC-4B85-4014-B282-039B605BAED9Q33639379-74840F10-98C5-41E2-92E1-42DDA462FA31Q34204238-65D0AAF7-AF51-4402-AA4C-8B4E903BEFC3Q35724898-9C5B643F-8F23-4F60-87ED-F625F1D2F4D0Q36032683-59438732-D065-4214-813B-8216FD77EA66Q36142620-67DCB297-85B5-4DD3-AE06-7EFC35276320Q36683880-7069C26F-263F-4101-84D5-9844EF5F1926Q36732592-422C93B9-24E9-4F77-A496-304BFFA902E8Q36949791-512CB0AE-E78D-4B8B-9987-2CEC1DAC9D83Q37482653-98D82B6D-C9AB-4549-A9C1-CFE9E83B1A9DQ37623840-69C84637-BD26-433A-8779-3214627E2B50Q37972673-AB62FA69-79AA-4D18-BBAE-A83EBB3F7E04Q37981609-0F2D1461-D9B7-4932-9180-AD031E0BD3DBQ41829072-774ADAF6-9C7C-44AA-ACB2-C702EFD0F1D5Q44205214-7D51D7A9-553F-4AE7-BEE6-35ADD3FFE742Q44216626-47905757-8A2E-4945-9170-D0B7E2756176Q46198493-F8C3BAA1-6D09-4D78-B4C2-710F664ED294Q47124483-91BC2BB0-CE13-4127-9D55-DE21C897C4B5Q47330547-AB3BA6FA-E3C2-4522-AE50-58DCD5A3B0DAQ47425174-0195A691-92A0-4670-AC3F-1F651AB9CC42Q53697345-839C5961-2455-459E-9882-C2C5399DC88AQ55085796-14DA0A6D-0479-412A-A2F2-725B6725BDC2
P2860
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
@en
type
label
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
@en
prefLabel
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
@en
P2093
P356
P1433
P1476
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
@en
P2093
P304
P356
10.1089/THY.1997.7.363
P577
1997-06-01T00:00:00Z